US Senate Confirms Robert Califf as FDA Commissioner

On Feb. 15, Robert Califf, MD, was confirmed to lead the US Food and Drug Administration (FDA) as commissioner for the second time. The margin was narrow: 50 Senators voted in favor, while 46 voted against.

Previously, cardiologist and researcher Dr. Califf served as FDA Commissioner during the Obama administration, from February 2016 to January 2017. During this earlier tenure, 89 senators voted in favor of his confirmation.

“He has the robust agency and private sector experience needed to help build on the success of the FDA in helping Americans get back to normal life,” said Senator Richard Burr (R-North Carolina). “He’s the leader we need today, but also for the future.”

Opposing senators doubted Dr. Califf’s fitness for the role because of his financial ties to the pharmaceutical industry. According to government records, between 2014 and 2019, he received more than $93,000 in consulting and other fees from 9 pharmaceutical companies.

In addition, some Republicans withdrew support after Dr. Califf agreed with the FDA’s decision to ease abortion pill restrictions. “It is clear that Dr. Califf will not fight for life, and I cannot support his nomination,” said Senator Jim Inhofe (R-Oklahoma).

Dr. Califf will take over the role from Janet Woodcock, MD, who has been serving as acting FDA Commissioner since January 2021.

Source: Reuters, February 15, 2022.